Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012-2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical Trial
about
Influenza immunology evaluation and correlates of protection: a focus on vaccines.Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine in US Children 6-35 Months of Age During 2013-2014: Results From A Phase II Randomized Trial.Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England.Immunogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccines in participants >/=3 years of age: A double-blind, randomized, parallel-controlled phase III clinical trial in ChinaTime to Change Dosing of Inactivated Quadrivalent Influenza Vaccine in Young Children: Evidence From a Phase III, Randomized, Controlled Trial.Influenza vaccines for preventing acute otitis media in infants and children.Influenza vaccines: Evaluation of the safety profile.Assessment of an optimized manufacturing process for inactivated quadrivalent influenza vaccine: a phase III, randomized, double-blind, safety and immunogenicity study in children and adults.Active surveillance of 2017 seasonal influenza vaccine safety: an observational cohort study of individuals aged 6 months and older in Australia
P2860
Q30385397-15241D6C-5268-4867-87F7-0BC85AF1CDC9Q33609256-7911EF10-39E5-4B93-82F5-82881D7E818AQ40052934-441A8308-D64E-429B-9EB9-896258889506Q40058830-4791606E-3348-4710-80B0-B417282C42CAQ40073913-B799103C-B3BF-4E02-8711-54AFBBE0D679Q47610224-9076A804-1785-4E44-A470-3C8FBD5479C9Q49345779-5B864368-7C27-49E5-B478-792D6073BB44Q52579975-003A1C27-D59A-4D7F-97E7-6EC963EBBD71Q57812045-4D5BB2AD-9EDC-430B-80D9-E872227283F3
P2860
Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35 Months of Age in 2012-2013: A Randomized, Double-Blind, Controlled, Multicenter, Multicountry, Clinical Trial
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Immunogenicity and Reactogenic ...... , Multicountry, Clinical Trial
@ast
Immunogenicity and Reactogenic ...... , Multicountry, Clinical Trial
@en
type
label
Immunogenicity and Reactogenic ...... , Multicountry, Clinical Trial
@ast
Immunogenicity and Reactogenic ...... , Multicountry, Clinical Trial
@en
prefLabel
Immunogenicity and Reactogenic ...... , Multicountry, Clinical Trial
@ast
Immunogenicity and Reactogenic ...... , Multicountry, Clinical Trial
@en
P2093
P2860
P50
P356
P1476
Immunogenicity and Reactogenic ...... , Multicountry, Clinical Trial
@en
P2093
Agustin Bueso
Lourdes Peña Mendez
Luis Cousin
Luis Rivera
Naresh Aggarwal
Varsha K Jain
Vijayalakshmi Chandrasekaran
P2860
P304
P356
10.1093/JPIDS/PIU098
P577
2014-10-20T00:00:00Z